(Englewood, New Jersey- August 25, 2014) Recently, Dr. Steven Elias (MD FACS FACPh), Director of Center for Vein Disease and the Wound Care Center of Englewood Hospital, NJ, traveled to China to offer his expertise and ultimately solidify approval of an exclusive Covidien technology by the Chinese FDA.
The technology, called ClosureFast™, is a minimally invasive therapy that is used to treat chronic venous insufficiency (CVI)—a condition that is often preceded by varicose veins. The technology requires no incisions or stitches, and allows patients to return to normal activity within a day.
Prior to Dr. Elias’ involvement, Covidien had been working for a number of years with the Chinese FDA to try to get ClosureFast™ approved for use in China. As one of the first physicians in the United States to use the technology, Dr. Elias was selected by Covidien to travel to China and appear before a panel of physicians and answer any questions they may have about the procedure before granting approval.
While in China, Dr. Elias met with 5 physicians on the FDA panel, fielding questions about vein diseases, the ClosureFast™ technology , results, and the technique. The results of the panel were favorable and ClosureFast™ has since been approved and is now sold in China.
“It was an honor and a privilege to travel to China and share expertise about a technology we in the US have been using for over 15 years,” says Dr. Elias. “When traveling to other countries I find that while working with people internationally can present the obvious language challenges, there is nothing more satisfying than sharing ideas and breaking boundaries across the international medical community.”
Dr. Elias will return to China to provide hands-on training for physicians on proper usage of ClosureFast™. Training will start in late 2014 and proceed through the New Year. As a leading expert in phlebology, Dr. Elias has trained physicians from all over the world.
About Dr. Steven Elias: Steve Elias MD FACS FACPh, is the Director of the Center for Vein Disease at Englewood Hospital. Dr. Steve Elias was recently named by VEIN Magazine as one of the 25 most influential professionals in vein care worldwide and voted “Best Doctor” in 2009, 2010 and 2011 by New York Magazine. In 2011, Dr. Elias was listed in The U.S. News & World Report Top Doctors in America. Castle Connolly as Top Doctor in the New York Metropolitan Area has named him for the last 9 years. He has been Visiting Professor at Yale University and has given keynote speeches at the Turkish Asian Vascular Society meeting and at the International Congress on Endovascular Interventions.
Dr. Elias lectures, publishes, and teaches nationally and internationally about minimally invasive vein care and surgical procedures. As Founder and Course Director of the Annual Vascular Fellows Course in Venous Disease, he trains young vascular surgeons in the treatment of vein problems. He is also the Course Director for the Expert Venous Management Course held at Englewood Hospital that teaches advanced vein care. His clinical interests encompass all aspects of vein care: spider veins, varicose veins, perforator and deep venous incompetence, and venous ulcers. Dr. Elias performs and teaches most minimally invasive vein procedures. His work also includes the prevention and treatment of DVT (Deep Venous Thrombosis).
Dr. Elias is a fellowship-trained vascular surgeon and is board certified in Phlebology and Surgery. Societal memberships include: The American Venous Forum, The American College of Phlebology, The Society for Clinical Vascular Surgery, American Venous Forum Foundation, American College of Phlebology Foundation, American College of Surgeons and the International Society of Cardiovascular Surgery. In addition, Dr. Elias is a member of The New York Society of Vascular Surgery and The New Jersey Vascular Society. He is a recipient of the Dardik Research and Education Award and The Fellows Education Award.
For more information about Dr. Elias or to set up an interview please contactAngela Thomas at 201 503 1333.